BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, April 29, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 20, 2020

View Archived Issues

Turning flexibility into toxicity

Read More

Taking the STING out of nuclear DNA

Read More

Taisho details antidepressant potential of V1b receptor antagonist THY-1773

Read More

Efflux pump furthers antibiotic resistance, but via unexpected mechanism

Read More

Polycomb protein EED inhibitors discovered at Shanghai Blueray Biopharma

Read More

XuanZhu Pharma identifies new ketohexokinase inhibitors

Read More

New STING receptor agonists identified at HitGen

Read More

Medshine Discovery patents c-Met inhibitors

Read More

Betta Pharmaceuticals identifies new SHP-2 inhibitors

Read More

Alkermes initiates phase II ARTISTRY-3 study of ALKS-4230

Read More

First patient dosed in phase I/II study of 4D-125

Read More

Trefoil Therapeutics initiates first clinical trial of TTHX-1114

Read More

Shionogi describes identification of clinical candidate P2X3 receptor antagonist S-600918

Read More

BioMarin receives complete response letter from FDA for valoctocogene roxaparvovec

Read More

Novel 3C-like protease inhibitors show efficacy in MERS-CoV-infected mice

Read More

Early interim data and regulatory update for phase II TRIDENT-1 study of repotrectinib

Read More

Enrollment ongoing in phase I study of ZF-874

Read More

Novartis initiates phase II study of LRX-712 in patients with knee osteoarthritis

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 28, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 28, 2026
  • Silhouette of head, brain

    Plasticity, properly parsed, provides psychiatric platform

    BioWorld
    If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
  • Roche identifies new TREM2 agonists

    BioWorld Science
    F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
  • Three red darts on target

    Sun Pharma to acquire Merck spinoff Organon for $11.75B

    BioWorld
    Sun Pharmaceuticals Industries Ltd. will pay $11.75 billion cash to acquire Organon & Co. The transaction is expected to close in early 2027. The addition of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing